The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6529 · Cited by 4,213
Wolff, A. C., Hammond, M. E. H., Hicks, D. G., Dowsett, M., McShane, L. M., Allison, K. H., Allred, D. C., Bartlett, J. M. S., Bilous, M., Fitzgibbons, P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.9984 · Cited by 4,030
Self-citationGoldhirsch, A., Winer, E. P., Coates, A. S., Gelber, R. D., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., Albain, K. S., André, F., Bergh, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt303 · Cited by 3,746
Self-citation3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Cardoso, F., Costa, A., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G., Biganzoli, L., Cardoso, M. J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw544 · Cited by 2,033
Self-citationThe CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104 · cited 3×
“Meijers-Heijboer H, van den Ouweland A, Klijn J et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.”
BackgroundBreast carcinoma in men: A population‐based study
Giordano, S. H., Cohen, D. S., Buzdar, A. U., Perkins, G., & Hortobagyi, G. N. (2004) · Cancer · doi:10.1002/cncr.20312 · Cited by 789
Self-citationESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Biganzoli, L., Blackwell, K. L., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu385 · Cited by 540 · cited 1×
“The Advanced Breast Cancer (ABC) International Consensus Guidelines state that in metastatic male BC patients who need treatment with an aromatase inhibitor, a concomitant LHRH agonist or orchiectomy is preferred [12, 13].”
BackgroundSelf-citationMale Breast Cancer: A Population-Based Comparison With Female Breast Cancer
Anderson, W. F., Jatoi, I., Tse, J., & Rosenberg, P. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.8162 · Cited by 495
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
Korde, L. A., Zujewski, J. A., Kamin, L., Giordano, S., Domchek, S., Anderson, W. F., Bartlett, J. M. S., Gelmon, K., Nahleh, Z., Bergh, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.5729 · Cited by 487
Self-citationHEMSELL, D. L., GRODIN, J. M., BRENNER, P. F., SIITERI, P. K., & MACDONALD, P. C. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-3-476 · Cited by 444
Cancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
Liede, A., Karlan, B. Y., & Narod, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 407
Bartlett, J. M. S., Bayani, J., Marshall, A., Dunn, J. A., Campbell, A., Cunningham, C., Sobol, M. S., Hall, P. S., Poole, C. J., Cameron, D. A., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw050 · Cited by 215
Self-citationAdjuvant systemic therapy for male breast carcinoma
Giordano, S. H., Perkins, G. H., Broglio, K., Garcia, S. G., Middleton, L. P., Buzdar, A. U., & Hortobagyi, G. N. (2005) · Cancer · doi:10.1002/cncr.21526 · Cited by 200
Self-citationEstrogen Suppression in Males: Metabolic Effects1
Mauras, N., O’Brien, K. O., Klein, K. O., & Hayes, V. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6676 · Cited by 190
Risk Factors for Male Breast Cancer—A Case-Control Study from Scandinavia
Ewertz, M., Holmberg, L., Tretli, S., Pedersen, B. V., & Kristensen, A. (2001) · Acta Oncologica · doi:10.1080/028418601750288181 · Cited by 172
The Genomic Landscape of Male Breast Cancers
Piscuoglio, S., Ng, C. K. Y., Murray, M. P., Guerini‐Rocco, E., Martelotto, L. G., Geyer, F. C., Bidard, F., Berman, S., Fusco, N., Sakr, R. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2840 · Cited by 172
Self-citationMale Versus Female Breast Cancers
Muir, D., Kanthan, R., & Kanthan, S. C. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-36-mvfb · Cited by 166
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
Eggemann, H., Ignatov, A., Smith, B. J., Altmann, U., von Minckwitz, G., Röhl, F. W., Jahn, M., & Costa, S.-D. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2355-3 · Cited by 164
Male breast carcinoma: increased awareness needed
White, J. S., Kearins, O., Dodwell, D. J., Horgan, K. J., Hanby, A. M., & Speirs, V. (2011) · Breast Cancer Research · doi:10.1186/bcr2930 · Cited by 138
Shaaban, A. M., Ball, G., Millican-Slater, R. A., Cserni, G., Benedetto, A. D., Dent, J., Fulford, L. G., Honarpisheh, H., Jordan, L. B., Jones, J. L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1856-9 · Cited by 133
Johansson, I., Nilsson, C., Berglund, P., Lauss, M., Ringnér, M., Olsson, H. L., Luts, L., Sim, E., Thorstenson, S., Fjällskog, M.-L., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3116 · Cited by 127
Self-citationHer-2/neu Gene Amplification and Protein Expression in Primary Male Breast Cancer
Rudlowski, C., Friedrichs, N., Faridi, A., Füzesi, L., Moll, R., Bastert, G., Rath, W. H., & Büttner, R. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000019953.92921.7e · Cited by 118
Breast cancer in men in the United States
Harlan, L. C., Zujewski, J. A., Goodman, M. T., & Stevens, J. L. (2010) · Cancer · doi:10.1002/cncr.25153 · Cited by 79
Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
Humphries, M. P., Rajan, S. S., Honarpisheh, H., Cserni, G., Dent, J., Fulford, L. G., Jordan, L. B., Jones, J. L., Kanthan, R., Litwiniuk, M. M., et al. (2017) · Scientific Reports · doi:10.1038/srep45293 · Cited by 78
Faratian, D., Munro, A. F., Twelves, C., & Bartlett, J. M. S. (2009) · Histopathology · doi:10.1111/j.1365-2559.2008.03191.x · Cited by 61
Self-citationCurigliano, G., Colleoni, M. A., Renne, G., Mazzarol, G., Gennari, R., Peruzzotti, G., de Braud, F., Robertson, C. E., Maiorano, E., Veronesi, P., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf166 · Cited by 43
Humphries, M. P., Rajan, S. S., Droop, A., Suleman, C. A. B., Carbone, C., Nilsson, C., Honarpisheh, H., Cserni, G., Dent, J., Fulford, L. G., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1952 · Cited by 25
Self-citationEstrogen Suppression in Males: Metabolic Effects
Mauras, N., Hayes, V. Y., & Klein, K. O. (1999) · Pediatric Research · doi:10.1203/00006450-199904020-00560 · Cited by 13
Cited by
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Self-citationPrimary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Self-citationEarly breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., & Senkus, E. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz173 · Cited by 2,214
Self-citationLoibl, S., Poortmans, P., Morrow, M., Denkert, C., & Curigliano, G. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32381-3 · Cited by 1,648
Epidemiology of male breast cancer
Konduri, S., Singh, M., Bobustuc, G., Rovin, R., & Kassam, A. (2020) · The Breast · doi:10.1016/j.breast.2020.08.010 · Cited by 411
Metadata
- Authors
- Cardoso, F., Bartlett, J. M. S., Slaets, L., van Deurzen, C. H. M., van Leeuwen-Stok, E., Porter, P., Linderholm, B., Hedenfalk, I., Schröder, C., Martens, J., Bayani, J., van Asperen, C., Murray, M., Hudis, C., Middleton, L., Vermeij, J., Punie, K., Fraser, J., Nowaczyk, M., Rubio, I. T., Aebi, S., Kelly, C., Ruddy, K. J., Winer, E., Nilsson, C., Lago, L. D., Korde, L., Benstead, K., Bogler, O., Goulioti, T., Peric, A., Litière, S., Aalders, K. C., Poncet, C., Tryfonidis, K., & Giordano, S. H.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 29
- Issue
- 2
- Pages
- 405-417
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2766828098
- Cited by
- 405
- References
- 28
- FWCI
- 24.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.